RCS - Tristel PLC - Capital Markets Day video update

TristelAnnouncement

Wed 16:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250806:nRSF2883Ua&default-theme=true

RNS Number : 2883U  Tristel PLC  06 August 2025

TRISTEL plc

("Tristel" or the "Company")

 

Capital Markets Day video update

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,
announces that the recording of the Capital Markets Day held on Tuesday, 29
July 2025 is now available on the Company's website.

 

To view the recording, please see here: Investor Hub - WE HAVE CHEMISTRY
(https://investors.tristel.com/investor-hub/?tab=presentations-webinars)

 

For further information please contact:

 

 Tristel plc                                                           Via Walbrook PR
 Matt Sassone, Chief Executive Officer                                 www.investors.tristel.com (https://investors.tristel.com/)

 Walbrook PR Ltd                                                       Tel: 020 7933 8780 or tristel@walbrookpr.com (mailto:tristel@walbrookpr.com)
 Paul McManus / Lianne Applegarth / Anna Dunphy  Mob: 07980 541 893/ 07584 391 303/ 07876 741 001

 Cavendish Capital Markets Ltd                                         Tel: 020 7220 0500
 Geoff Nash / Trisyia Jamaludin (Corporate Finance)
 Sunila de Silva (Corporate Broking) / Louise Talbot (Sales)

 

 

About Tristel plc

Tristel plc is a global infection prevention company focussed on the
manufacture and supply of products using its unique proprietary chlorine
dioxide (ClO(2)) chemistry. The Company is a market leader in manual
decontamination of medical devices, supplying hospitals under the Tristel
(https://tristel.com/) brand, and under the Cache
(https://thecachecollection.com/) brand provides products for sporicidal
surface disinfection, a more sustainable alternative to commonly used
pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near
Cambridge, and operates globally employing approximately 270 people across 16
subsidiaries selling into 40+ countries. The Company targets annual revenue
growth of between 10% and 15% and an EBITDA margin of at least 25% and the
business is profitable, with no debt and has a progressive dividend policy.

 

The Company has been listed on the London Stock Exchange's AIM market since
2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit:
https://tristel.com (https://tristel.com)

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRASSUFLMEISEIA